Linkage Tool: Avian Influenza One Health Research funding opportunity
To achieve the goals and objectives of the Avian Influenza One Health Research Funding Opportunity, strong connections are essential. One of the ways CIHR is supporting the development of such connections is through this Linkage Tool. The table below provides information submitted by individuals and/or organizations interested in sharing information and/or establishing collaborations in relation to the Avian Influenza funding opportunity.
Information is provided on a voluntary basis and in no way confers any advantages in the evaluation and/or funding of applications.
To submit your information, please complete the short survey.
Notice
The information is provided in the language in which it was submitted by the respondent.
| Contact information | Location | Stakeholder/ Participant Type |
Area(s) of Interest | Additional Information |
|---|---|---|---|---|
| Dr. Melanie Courtot mcourtot@oicr.on.ca 647-259-4240 Ontario Institute for Cancer Research and University of Toronto |
Ontario |
Independent Researcher |
|
My team developed the Overture suite, https://www.overture.bio/, which enables the deployment of big data portals for genomic data. We lead the development of the VirusSeq portal for COVID data, https://virusseq-dataportal.ca/. I was also a PHAC/CIHR Influenza Research Network (PCIRN) co-investigator. For more information, please visit: https://courtotlab.genomeinformatics.org/ |
| Andrew Pinto Clinician-Scientist upstreamlab@unityhealth.to 416-864-6060 x76148 Upstream Lab & University of Toronto |
Ontario, Alberta, British Columbia, Manitoba, Newfoundland and Labrador, Quebec |
Independent Researcher Health Professional |
respiratory surveillance; clinical trials; pandemic preparedness; accelerating biomanufacturing; health equity |
Our team was recently funded for PREPARED, a national initiative focused on 1) improving respiratory surveillance in primary care and emergency departments; 2) linking patients with acute infections to trials; 3) accelerating Canadian biomanufacturing of diagnostics, therapeutics and vaccines. For more information, please visit: https://upstreamlab. org/project/ prepared/ |
| Anh Tran Associate Research Officer Anh.Tran@nrc-cnrc.gc.ca 613-298-7516 National Research Council Canada |
Ontario Ottawa |
Independent Researcher Federal Government agency |
Vaccine development to respiratory virus infection, specifically Highly Pathogenic Avian Influenza and SARS-COV-2. Research focus also on host immunity to infection and vaccination. |
Research Scientist at the National Research Council Canada (NRC) in Ottawa, leading the NRC's small animal CL-3 facility for HPAI and SARS-COV-2 research. |
| Ralph Pantophlet Professor rpantophlet@sfu.ca 778-782-8648 Simon Fraser University |
British Columbia |
Independent Researcher |
anti-viral antibodies, humoral immunity, vaccines |
For more information, please visit: Ralph Pantophlet - Faculty of Health Sciences - Simon Fraser University |
| Nelson Lee Professor, Director nelsonls.lee@utoronto.ca 416-978-0901 Institute for Pandemics, Dalla Lana School of Public Health, University of Toronto |
Ontario |
Independent Researcher Health Professional |
public health, epidemiology, health policy; vaccines, antivirals, non-pharmaceutical interventions; human-animal interface, occupational exposure risk; surveillance; modeling; clinical and epidemiological studies |
IFP is an Institutional Strategic Initiative of the University of Toronto to advance interdisciplinary research on pandemics and pubic health threats; currently with 170+ faculty members from 11 divisions. Our expertise in avian influenza includes epidemiology / clinical studies; surveillance; modeling, AI, and public health response. For more information, please visit: https://pandemics.utoronto.ca/research-themes/ |
- Date modified: